JnJ gets European Commission nod for subcutaneous Darzalex-based quadruplet regimen for newly diagnosed multiple myeloma Ruchika Sharma11 April 2025 10:30 AM ISTBelgium: Janssen-Cilag International NV, a Johnson & Johnson company, has received approval from the European Commission (EC) for an...
Darzalex-based quadruplet regimen receives positive CHMP opinion for transplant-eligible patients with newly diagnosed multiple myeloma Ruchika Sharma22 Sept 2024 12:30 PM ISTBeerse: Janssen-Cilag International NV, a Johnson & Johnson company, has announced that the Committee for Medicinal Products for Human Use...
Johnson & Johnson beat estimates for Q2 profit, revenue Ruchika Sharma18 July 2024 4:53 PM ISTLondon:Johnson & Johnson exceeded expectations in its second-quarter profit and revenue announced on Wednesday, propelled by robust sales of its...
Delhi police crack down on fake cancer drug racket, seven arrested Ruchika Sharma13 March 2024 4:03 PM ISTNew Delhi: In a groundbreaking operation, the Delhi Police's crime branch has cracked down on a sprawling racket involved in the manufacturing and...
J&J boosts profit forecasting as it invests in chemotherapy, medical devices Kajal Rajput21 July 2023 3:08 PM ISTNew Delhi: Johnson and Johnson raised its 2023 profit forecast on Thursday, banking on the strength in its medical devices business and demand for its...
JnJ forecasts strong 2023 profit on pharma boost Ruchika Sharma26 Jan 2023 1:00 PM ISTBengaluru: Johnson & Johnson on Tuesday forecast annual profit above Wall Street estimates, as strong demand for its drugs such as cancer...
Johnson and Johnson cancer drug sales help weather hit from stronger dollar Ruchika Sharma20 July 2022 2:00 PM ISTThe company said it was raising prices of some products like painkillers and mouthwash in response to inflation.
Medical devices, prescription drugs boost JnJ earning in Q4 Ruchika Sharma27 Jan 2022 9:00 AM ISTWashington: Growing prescription drug and medical device sales nudged Johnson & Johnson past fourth-quarter earnings expectations, and the...
FDA approves Empliciti to treat multiple myeloma Meghna A Singhania3 Dec 2015 12:35 PM ISTToday the U.S. Food and Drug Administration granted approval for Empliciti (elotuzumab) in combination with two other therapies to treat people with...
FDA approves J&J drug-Darzalex for advanced multiple myeloma Pooja Bhatia Bhatia17 Nov 2015 9:53 AM ISTThe U.S. Food and Drug Administration on Monday said it had approved Darzalex (daratumumab) for patients who had already undergone at least three...
